KFDA to review 855 of new drugs in few years.

Published: 2004-09-21 06:58:00

Updated: 2004-09-21 06:58:00

At present the total 855 drugs should be reviewed, of which the products from GSK among the foreign multinational drug corporations and Dong-A among the domestic drug firms are predominant. Lipitor, Plavix and Aprobel will be completed its review soon.

The drug review system is to re-evaluate ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK